Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adverum Biotechnologies

2.32
-0.1700-6.83%
Pre-market: 2.320.00000.00%08:00 EDT
Volume:2.80M
Turnover:6.53M
Market Cap:48.47M
PE:-0.32
High:2.56
Open:2.48
Low:2.27
Close:2.49
Loading ...
Jun 16, 2022

Major Issues Report

8-K - Current report
Jun 06, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 29, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 17, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2021

Major Issues Report

8-K - Current report
Dec 08, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Dec 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 09, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 11, 2021

Major Issues Report

8-K - Current report